Switching patients at high risk of PML from natalizumab to another disease-modifying therapy
Gavin Giovannoni, Monica Marta, Angharad Davis, Benjamin Turner, Sharmilee Gnanapavan, Klaus Schmierer
Practical Neurology Oct 2016, 16 (5) 389-393; DOI: 10.1136/practneurol-2015-001355